HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lectin Histochemistry Shows WGA, PHA-L and HPA Binding Increases During Progression of Human Colorectal Cancer.

AbstractBACKGROUND/AIM:
Most colorectal carcinomas develop from an adenoma-carcinoma sequence to metastatic disease. The aim of the present study was to use lectins, carbohydrate-binding proteins, to detect changes in glycosylation during this malignant progression.
MATERIALS AND METHODS:
Sections from normal colorectal mucosa, high-grade intraepithelial neoplasia, submucosal colorectal carcinoma and metastases from patients who underwent colorectal surgery were stained by lectins with different sugar specificities namely agglutins from Wheatgerm (WGA), Helix pomatia (HPA), Phaseolus vulgaris (PHA-L), Ulex europaeus (UEA-I), Sambucus nigra (SNA-I), Canavalia ensiformis (Con A), Galanthus nivalis (GNA) and Dolichos biflorus (DBA).
RESULTS:
Binding patterns of all lectins except SNA-I, Con A and DBA changed during the adenoma-carcinoma sequence.
CONCLUSION:
The results indicate that lectins specific for mannose, N-acetylgalactosamine, N-acetylglucosamine, sialic acid, β-1,6-branched oligosaccharides and α-1-fucose may be associated with malignant progression.
AuthorsPia Hägerbäumer, Michael Vieth, Mario Anders, Udo Schumacher
JournalAnticancer research (Anticancer Res) Vol. 35 Issue 10 Pg. 5333-9 (Oct 2015) ISSN: 1791-7530 [Electronic] Greece
PMID26408694 (Publication Type: Journal Article)
CopyrightCopyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Chemical References
  • Lectins
Topics
  • Cell Transformation, Neoplastic (metabolism, pathology)
  • Colorectal Neoplasms (metabolism, pathology)
  • Disease Progression
  • Glycosylation
  • Histocytochemistry (methods)
  • Humans
  • Lectins (metabolism)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: